ANGIOTENSIN PROFILES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES WITH COMBINATION THERAPY OF EMPAGLIFLOZIN AND LINAGLIPTIN VERSUS METFORMIN AND INSULIN GLARGINE

Bosch A, Poglitsch M, Kannenkeril D, Ott C, Pietschner R, Striepe K, Schiffer M, Schmieder R (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Journal of Hypertension Lippincott, Williams & Wilkins

Publisher: LIPPINCOTT WILLIAMS & WILKINS

City/Town: PHILADELPHIA

Pages Range: E283-E284

Conference Proceedings Title: JOURNAL OF HYPERTENSION

DOI: 10.1097/01.hjh.0000838460.41318.ce

Authors with CRIS profile

Agnes Bosch Department of Medicine 4 – Nephrology and Hypertension Christian Ott Department of Medicine 4 – Nephrology and Hypertension Robert Pietschner Department of Medicine 4 – Nephrology and Hypertension Kristina Striepe Professur für Innere Medizin (Nephrologie) Mario Schiffer Lehrstuhl für Innere Medizin IV Roland Schmieder Professur für Innere Medizin (Nephrologie)

Involved external institutions

Attoquant Diagnostics GmbH

Germany (DE)

How to cite

APA:

Bosch, A., Poglitsch, M., Kannenkeril, D., Ott, C., Pietschner, R., Striepe, K.,... Schmieder, R. (2022). ANGIOTENSIN PROFILES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES WITH COMBINATION THERAPY OF EMPAGLIFLOZIN AND LINAGLIPTIN VERSUS METFORMIN AND INSULIN GLARGINE. In JOURNAL OF HYPERTENSION (pp. E283-E284). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

MLA:

Bosch, Agnes, et al. "ANGIOTENSIN PROFILES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES WITH COMBINATION THERAPY OF EMPAGLIFLOZIN AND LINAGLIPTIN VERSUS METFORMIN AND INSULIN GLARGINE." Proceedings of the JOURNAL OF HYPERTENSION PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2022. E283-E284.

BibTeX: Download